Background Obesity is associated with cardiac dysfunction, atherosclerosis, and increased cardiovascular risk. It can be lead to obesity cardiomyopathy and severe heart failure, which in turn raise morbidity and mortality while carrying a negative impact on quality of life. There is increasing clinical and mechanistic evidence on the metabolic and weight loss effects of bariatric surgery on improving cardiac structure and function in obese patients. Objectives The objective of this study was to quantify the effects of bariatric surgery on cardiac structure and function by appraising cardiac imaging changes before and after metabolic operations. Methods This is a comprehensive systematic review of studies reporting pre-operative and post-operative echocardiographic or magnetic resonance cardiac indices in obese patients undergoing bariatric surgery. Studies were quality scored, and data were meta-analyzed using random effects modeling. Results Bariatric surgery is associated with significant improvements in the weighted incidence of a number of cardiac indices including a decrease in left ventricular mass index (11.2 %, 95 % confidence intervals (CI) 8.2-14.1 %), left ventricular end-diastolic volume (13.28 ml, 95 % CI 5.22-21.34 ml), and left atrium diameter (1.967 mm, 95 % CI 0.980-2.954). There were beneficial increases in left ventricular ejection fraction (1.198 %, 95 %CI −0.050-2.347) and E/A ratio (0.189 %, 95 %CI −0.113-0.265). Conclusions Bariatric surgery offers beneficial cardiac effects on diastolic function, systolic function, and myocardial structure in obese patients. These may derive from surgical modulation of an enterocardiac axis. Future studies must focus on higher evidence levels to better identify the most successful bariatric approaches in preventing and treating the broad spectrum of obesity-associated heart disease while also enhancing treatment strategies in the management of obesity cardiomyopathy. 
Conclusions Bariatric surgery offers beneficial cardiac effects on diastolic function, systolic function, and myocardial structure in obese patients. These may derive from surgical modulation of an enterocardiac axis. Future studies must focus on higher evidence levels to better identify the most successful bariatric approaches in preventing and treating the broad spectrum of obesity-associated heart disease while also enhancing treatment strategies in the management of obesity cardiomyopathy. 
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Introduction
The global prevalence of both obesity and cardiovascular disease continues to rise. Obesity has doubled since 1980 where an estimated 39 % of adults globally are overweight and 13 % of adults are obese [1], while cardiovascular disease and cardiac failure carry an impact of 31 % of all global deaths in 2012 [2] . Obesity is recognized as a risk factor for cardiac dysfunction, atherosclerosis, and cardiovascular disease [3] . When combined with other risk factors such as hypertension, dyslipidaemia, and diabetes mellitus, it is known as Bmetabolic syndrome^which in itself is an independent predictor of cardiac dysfunction and cardiovascular disease [4] .
Evidence from epidemiological studies (such as the Framingham Heart Study and the National Health and Nutrition Examination Survey) in addition to cardiac imaging trials suggest that long-term obesity can lead to LV dilation and hypertrophy with resultant cardiac failure [3, 5] . These structural changes cause a deterioration of ventricular contractile function and distortion of shape and cavity resulting in maladaptive LV remodeling, which can progress to non-ischaemic dilated cardiomyopathy [3, 6] .
The literature suggests that weight loss achieved by any means may improve cardiac structure and function (through reverse remodeling) and decreased cardiovascular risk [7] . However, lifestyle (diet and exercise) and pharmacotherapy have not yet demonstrated sustainable long-term weight loss in the majority of patients [8, 9] . Bariatric surgery offers the most efficacious and sustained weight loss in morbidly obese individuals; which in turn can result in favorable modulation of cardiac function cardiovascular risk factors [3] .
The beneficial effects of bariatric procedures on cardiac functional imaging endpoints (such as echocardiogram and MRI) have been demonstrated in a number of studies. Although previous systematic reviews in this field have been performed [10, 11] , our objective was to accrue all the available data in this area which almost doubles the study number of the last literature analysis [10] . Our aim was to complete the largest and most comprehensive systematically review and meta-analysis to date examining the data from cardiac imaging studies to quantify the impact of bariatric surgery on cardiac structure and function in obese patients.
Methods
Literature Search
A literature search was performed using PubMed, Embase, Ovid, and Cochrane databases using combinations of the terms Bbariatric surgery^or Bmetabolic surgery^or Bweight loss surgery^or Bobesity surgery^and Bechocardiography^or Bmagnetic resonance imaging^or Bcardiac imaging^or Bcardiac dimensions^or Bventricular dimensions.^The last date for this search was 11 June 2015. Figure 1 outlines our search strategy. All studies are listed in Table 1 .
Inclusion and Exclusion Criteria
All studies reporting echocardiographic or magnetic resonance cardiac parameters of structure and function were included. Studies were excluded from analysis if inconsistency of data did not allow valid extraction and studies did not report both pre-operative and post-operative data. A minimum follow-up of 3 months post surgery was required for inclusion, and quality scoring was performed utilizing the NewcastleOttawa scale.
Statistical Analysis
Meta-analysis was performed in line with recommendations from the Cochrane Collaboration and PRISMA guidelines. Analysis was conducted using Stata version 12 (StateCorp LP, College Station, TX).
Data was analyzed using a random effects model. Continuous data were investigated using weighted mean difference (WMD) and 95 % confidence intervals (CI). Proportion difference between outcomes was also calculated and pooled through DerSimonian and Laird random effects modeling. Results were computed and represented on forest plots. Inter-study heterogeneity was explored using the I 2 statistic: a value of <30 % was considered low, 30-60 % as moderate, and >60 % is high. The Newcastle-Ottawa scale was utilized for quality scoring.
Results
Forty studies were found that fulfilled the inclusion criteria, producing a pooled data set of 1486 patients (Table 1) . Twenty-six of these studies were non-randomized prospective observational studies and 14 were retrospective cohort studies. Two studies [12, 13] had two different cohorts within the same study so these were analyzed individually. Five studies used MRI (CMR) to visualize cardiac parameters and 37 used echocardiography. The types of operation performed and the parameters reported across the forty publications varied markedly and are shown in Table 1 . Some publications used the same cohort of patients with the same outcomes; consequently, we only utilized the single most up-to-date study on these cohorts for these outcomes. The overall weighted mean follow-up was 18.2 months for patients with a BMI of 47.2 kg/m 2 . Cardiac imaging outcome parameters are listed in Table 2 .
Cardiac Geometry
LV Mass
Absolute LV mass (LVM) was reported in 24 studies. Pooled analysis demonstrated a weighted mean decrease in the LVM 29.80 g (95 % CI 24.06-35.54, p<0.001) after surgery; there was moderate heterogeneity between studies (I 2 55 %).
LV Mass Index
Three studies reported on LVM indexed to height (m), 13 indexed to height (m 2.7 ), and 6 to body surface area (m 2 ). Proportional analysis of cardiac imaging findings in the total 22 studies demonstrated a weighted mean decrease of 11.2 % (95 % CI 0.082-0.141, p<0.001) in LV mass index (LVMI) after surgery; there was a moderate heterogeneity between studies (I 2 32.8 %).
LV End-Diastolic Volume
Thirteen studies reported on of LV end-diastolic volume (LVEDV) to reveal a decrease of 13.28 ml (95 % CI 5.22-31.34 ml, p=0.001); there was high heterogeneity between studies (I 2 85.9 %).
LV End-Systolic Volume
Ten studies reported on of LV end-systolic volume (LVESV) to reveal a decrease of 4.99 ml (95 % CI 0.35-9.62 ml, p=0.035); there was high heterogeneity between studies (I 2 87.3 %).
Diastolic Function
E/A Ratio
Twenty-one studies reported on the E/A ratio before and after surgery to reveal a weighted mean increase of 0.189 (95 % CI 0.113-0.265, p<0.001) from a baseline of 1.16. There was high heterogeneity between studies (I 2 82.0 %).
Left Atrium Diameter
Fifteen studies reported on the left atrium (LA) diameter before and after surgery. Pooled analysis of cardiac imaging findings demonstrated a weighted mean decrease in the LA diameter of 1.967 mm (95 % CI 0.980-2.954, p<0.001) after surgery; there was a high heterogeneity between studies (I 2 79.7 %).
Systolic Function
LV Ejection Fraction
Twenty-two studies reported on LV ejection fraction (LVEF) before and after surgery. Pooled analysis of cardiac imaging findings demonstrated a weighted mean increase in LVEF of 1.198 % (95 % CI 0.050-2.347, p=0.041) after surgery; there was a high heterogeneity between studies (I 2 74.2 %). 
Discussion
Overall, our analysis demonstrates that cardiac structure and function are both consistently improved in bariatric surgical subjects. These global changes include statistically significant improvements in cardiac geometry, diastolic function, and systolic function. The beneficial effects are demonstrated after significant weight loss (weighted mean reduction of BMI by 13.51 kg/m 2 ) and across changing modalities of cardiac imaging including echocardiography and MRI. Our systematic review and meta-analysis represents the largest and most comprehensive to date, with 40 studies included (almost doubling previous systematic assessments). Although research in this field largely consists of small-sized studies, the findings confirm and extend the previous evidence with improvements in cardiac geometry and diastolic function. A novel finding is a small but statistically significant improvement increase in systolic function identified through LV ejection fraction and a demonstrable proportional change in measures of cardiac mass index to accommodate all data sets available. Three studies were included which used CMR to evaluate cardiac indices rather than echocardiography which has been shown to be more precise and accurate [14] in estimating LV mass.
Cardiac Geometry
Obesity is a recognized driver of increasing left ventricular mass [15] with obese men showing predominantly concentric hypertrophy and obese women exhibiting both eccentric and concentric hypertrophy [16] . Our results demonstrate a statistically significant weighted proportional decrease of 11.2 % in LVMI after surgery (p<0.001) supporting the notion that LV 2 , PWT posterior wall thickness, IVST interventricular septal thickness, RWT relative wall thickness, IVRT isovolumic relaxation time reverse remodeling occurs after bariatric surgery (Fig. 2) . There was also a substantial drop in LV mass as a measure of improvement in left ventricular hypertrophy (LVH) which may account for the long-term decrease in cardiovascular mortality observed in bariatric patients [3] .
This may result from the reversal of pathological diastolic dysfunction and reduced ventricular filling [17] , depressed ventricular contractility, reduced coronary reserve, and arrhythmogenic electrical dysfunction. Additionally, our results demonstrating an improvement in posterior wall thickness, interventricular septal thickness, and relative wall thickness also support the concept of beneficial reverse remodeling of left ventricular hypertrophy toward a less concentric pattern in bariatric subjects. Both measures of end-systolic and enddiastolic volume and diameter dimensions also demonstrated improvements, indicating increased filling and relaxation of the left ventricle after bariatric surgery. 
Diastolic Dysfunction
Our meta-analysis demonstrates that bariatric surgery beneficially modulates echocardiographic markers of diastolic dysfunction. Post-operative E/A ratio is increased in all but one study. This is likely to be an improvement in pseudonormal (grade II) diastolic dysfunction associated with obesity. Furthermore, we demonstrate a significant improvement in LA diameter (p<0.001). LA enlargement reflects chronic exposure to increased LV filling pressure and therefore is an important measure of diastolic function [18] . LVMI is also an independent predictor of LA enlargement, which in turn is associated with adverse cardiovascular outcomes. Furthermore, increasing LA diameters are associated with a risk of developing atrial fibrillation so that a trend toward normalization of this chamber reflects the favorable impact of bariatric surgery on diastolic function and concurrent decreased risk of arrhythmogenesis. Additionally, left atrium size is well recognized to be associated with obstructive sleep apnea, which has also been demonstrated to decrease significantly after bariatric surgery [19, 20] .
LV Systolic Function
Morbid obesity has long been established as impairing LV systolic function, although in many cases this is only subclinical and only seen on echocardiogram. Our meta-analysis demonstrated a modest yet significant increase in LVEF after surgery with high heterogeneity between studies. This novel finding may be due to the large dataset applied within this study (as individual reports and previous analyses may have been underpowered). Alpert et al. [21] demonstrated that improvements in systolic function only occur in those obese individuals whose systolic function was depressed preoperatively and that the best improvement of systolic parameters after surgery occurs in those who have been morbidly obese for longer periods of time [22] . However, bariatric surgery might lead to symptomatic improvement in all stages of obesity-related cardiomyopathy and can improve systolic function even in patients with severe heart failure who are waiting a heart transplant [23] . The overall weighted baseline LV ejection fraction across all studies was 62 %. This normal value may suggest that many of the patients in reported studies suffered from uncomplicated obesity (without cardiac sequelae) or even a selection bias for surgery for those without cardiac dysfunction. Nevertheless, the finding of a significant improvement in this parameter is noticeable and may represent the supra-physiological activity of metabolic operations. These include the possibility of direct gut hormonal inotropic action on the myocardium through an enterocardiac axis [3] .
Mechanisms accounting for the profound improvements in cardiac imaging after bariatric surgery derive from models explaining how these operations achieve beneficial reverse remodeling. The classical haemodynamic or mechanical weight-dependent effect of bariatric surgery (with a decreasing circulating volume) is no longer thought to be solely responsible for the reverse remodeling seen after surgery, as the beneficial effects can be independent from changes in blood pressure [11, 24] . Consequently, bariatric cardiac effects are also considered to derive from the profound metabolic (weight independent) effects of bariatric surgery, so that the reverse remodeling of cardiac geometry and function can result from the joint effects of weight loss and metabolic enhancement [25] . The recent combined metabolic and haemodynamic hypothesis [25] may better explain favorable surgical effects. Here, metabolites such as leptin and other adipokines are reported to drive ventricular hypertrophy in early obesity and then increasing circulating volume contributing to ventricular dilatation and hypertrophy in morbid obesity [25, 26] . Following bariatric surgery, the reversal of metabolic dysfunction can then contribute to improved cardiac structure and function.
The metabolic components of bariatric surgery that contribute to cardiac reverse remodeling include the systemic BRAVE effects (bile flow alteration, reduction in gastric size, anatomical gut rearrangement, vagal manipulation, and enteric gut hormone manipulation) [27] . These effects occur almost instantaneously after surgery [20, [27] [28] [29] and may offer a paradigm to identify the profound downstream mechanisms that achieve improvements in glucose metabolism, insulin resistance, gut hormonal release, microbiota, and adipokine modulation [28, 30] demonstrated by these operations which in turn may offer a 'bionic' [29] level of resolution in obesityassociated cardiac dysfunction.
Manipulation of enteric gut hormones has been shown to demonstrate beneficial effects on cardiac function via the enterocardiac axis [3, 25, 31] . Hormones, such as secretin (produced in the duodenum), glucagon (produced in the pancreas), and vasoactive intestinal peptide (produced in the pancreas, gut, and brain), act as inotropes by activating cardiac membrane adenylate cyclase, a key enzyme in cardiac cell communication [32] . The mechanisms for this are currently unclear, but it is thought that cardiac energy metabolism is enhanced through TCA cycle intermediaries, cardiorenal protective activity, and biochemical caloric restriction [33, 34] .
Moreover two key hormones, glucagon-like peptide-1 (GLP-1) and ghrelin, also modulate cardiac function. GLP-1 is well documented to raise satiety, improve insulin secretion, and is increased after bariatric surgery [31] . It has been shown to improve LV systolic dysfunction after myocardial infarction in humans [35] and improve functional status in patients with chronic heart failure [36] .
There is conflicting data on the appetite-stimulating hormone ghrelin following bariatric surgery [31] ; however, studies suggest that when it is infused into patients with cardiac failure, stroke volume index, ejection fraction, and cardiac index are all improved with a decrease in LV wall stress [37] . Finally, adipokines such as leptin, TNFα, and adiponectin demonstrate cardiovascular activity and have been shown to significantly decrease for up to 2 years after bariatric surgery [38] . Circulating leptin levels correlate well with LV mass in morbid obesity both before and after bariatric surgery [39] and may therefore also contribute to the beneficial cardiac effects of bariatric operations.
Strengths and Limitations
This meta-analysis statistically appraises pooled data collected from 1486 patients in 40 studies. It is the largest study to date of cardiac indices pre-and post-bariatric surgery. However, the results presented here should be considered in the context of a number of limitations. Firstly, the heterogeneity of the studies identifying cardiac structural and functional change represents a significant interpretive limitation. Patient selection and demographics, follow-up time, cardiac imaging technique, and bariatric procedure performed all vary between studies. The quality scoring of the studies was generally very low, with only seven studies scoring greater than 7 on the Newcastle-Ottawa Scale. Echocardiographic studies are also vulnerable to subjectivity and reporting biases of interpreting echocardiograms. This can be difficult in obese patients, with limited acoustic windows and suboptimal data. There was also great variation in the year of publication, ranging from 1990 to 2014. As such, our analysis may not reflect the difference between current and older weight loss therapies, or improvements in echocardiographic or CMR techniques.
Secondly, all of the trials included are limited by their study design. The majority were prospective observational studies, with 14 retrospective studies. There were no randomized control trials. Therefore, there may be a degree of publication bias of these positive results.
Conclusion
In summary, our meta-analysis and systematic review on the effect of bariatric surgery on cardiac structure assessed by imaging suggests that these procedures are associated with a significant improvement in cardiac morphology and function. This supports the role of bariatric surgery on beneficial reverse cardiac remodeling after surgery although the significant heterogeneity between studies limits our interpretation of results. Further studies, in particular randomized control trials with mechanistic studies, are justified to clarify the role of surgery in obesity and cardiac dysfunction and may help to better select patient cohorts and appropriate procedures to address the severe mortality and morbidity of obesity-associated cardiac disease.
